Shah O’Brien, P.; Xi, Y.; Miller, J.R.; Brownell, A.L.; Zeng, Q.; Yoo, G.H.; Garshott, D.M.; O’Brien, M.B.; Galinato, A.E.; Cai, P.;
et al. Disulfiram (Antabuse) Activates ROS-Dependent ER Stress and Apoptosis in Oral Cavity Squamous Cell Carcinoma. J. Clin. Med. 2019, 8, 611.
https://doi.org/10.3390/jcm8050611
AMA Style
Shah O’Brien P, Xi Y, Miller JR, Brownell AL, Zeng Q, Yoo GH, Garshott DM, O’Brien MB, Galinato AE, Cai P,
et al. Disulfiram (Antabuse) Activates ROS-Dependent ER Stress and Apoptosis in Oral Cavity Squamous Cell Carcinoma. Journal of Clinical Medicine. 2019; 8(5):611.
https://doi.org/10.3390/jcm8050611
Chicago/Turabian Style
Shah O’Brien, Priyanka, Yue Xi, Justin R. Miller, Amy L. Brownell, Qinghua Zeng, George H. Yoo, Danielle M. Garshott, Matthew B. O’Brien, Anthony E. Galinato, Peter Cai,
and et al. 2019. "Disulfiram (Antabuse) Activates ROS-Dependent ER Stress and Apoptosis in Oral Cavity Squamous Cell Carcinoma" Journal of Clinical Medicine 8, no. 5: 611.
https://doi.org/10.3390/jcm8050611
APA Style
Shah O’Brien, P., Xi, Y., Miller, J. R., Brownell, A. L., Zeng, Q., Yoo, G. H., Garshott, D. M., O’Brien, M. B., Galinato, A. E., Cai, P., Narula, N., Callaghan, M. U., Kaufman, R. J., & Fribley, A. M.
(2019). Disulfiram (Antabuse) Activates ROS-Dependent ER Stress and Apoptosis in Oral Cavity Squamous Cell Carcinoma. Journal of Clinical Medicine, 8(5), 611.
https://doi.org/10.3390/jcm8050611